Nunes Santos C, Kuehn H, Boast B, Hwang S, Kuhns D, Stoddard J, et al. Inherited ARPC5 mutations cause an actinopathy impairing cell motility and disrupting cytokine signaling. Nat Commun. 2023;14:3708 pubmed publisher

Moriyama M, Lucas C, Monteiro V, Iwasaki A. Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants. Proc Natl Acad Sci U S A. 2023;120:e2221652120 pubmed publisher

Silva R, Huang Y, Nguyen A, Hsieh C, Olaluwoye O, Kaoud T, et al. Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses. elife. 2023;12: pubmed publisher

Chen C, Wang Z, Sun Z, Li W, Dimitrov D. Development of an efficient method for selection of stable cell pools for protein expression and surface display with Expi293F cells. Cell Biochem Funct. 2023;41:355-364 pubmed publisher

Navare A, Mast F, Olivier J, Bertomeu T, Neal M, Carpp L, et al. Viral protein engagement of GBF1 induces host cell vulnerability through synthetic lethality. J Cell Biol. 2022;221: pubmed publisher

Li S, Bern M, Miao B, Fan C, Xing X, Inoue T, et al. The transcription factor Bach2 negatively regulates murine natural killer cell maturation and function. elife. 2022;11: pubmed publisher

Taft J, Weber C, Gao B, Ehling R, Han J, Frei L, et al. Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain. Cell. 2022;185:4008-4022.e14 pubmed publisher

Bo Q, Yang F, Li Y, Meng X, Zhang H, Zhou Y, et al. Structural insights into the activation of somatostatin receptor 2 by cyclic SST analogues. Cell Discov. 2022;8:47 pubmed publisher

Zhu I, Liu R, Garcia J, Hyrenius Wittsten A, Piraner D, Alavi J, et al. Modular design of synthetic receptors for programmed gene regulation in cell therapies. Cell. 2022;185:1431-1443.e16 pubmed publisher

Reuschl A, Mesner D, Shivkumar M, Whelan M, Pallett L, Guerra Assun xe7 xe3 o J, et al. HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells. Cell Rep. 2022;39:110650 pubmed publisher

Veatch J, Lee S, Shasha C, Singhi N, Szeto J, Moshiri A, et al. Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function. Cancer Cell. 2022;40:393-409.e9 pubmed publisher

Ye L, Park J, Peng L, Yang Q, Chow R, Lam S, et al. A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy. Cell Metab. 2022;34:595-614.e14 pubmed publisher

Galli A, Fahnøe U, Bukh J. High recombination rate of hepatitis C virus revealed by a green fluorescent protein reconstitution cell system. Virus Evol. 2022;8:veab106 pubmed publisher

Sabatino J, Mittl K, Rowles W, McPolin K, Rajan J, Laurie M, et al. Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine-induced antibody and T cell immunity and function. JCI Insight. 2022;7: pubmed publisher

Shao Z, Shen Q, Yao B, Mao C, Chen L, Zhang H, et al. Identification and mechanism of G protein-biased ligands for chemokine receptor CCR1. Nat Chem Biol. 2022;18:264-271 pubmed publisher

Chen J, Chow R, Song E, Mao T, Israelow B, Kamath K, et al. High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells. Sci Immunol. 2022;7:eabl5652 pubmed publisher

Muliaditan T, Halim L, Whilding L, Draper B, Achkova D, Kausar F, et al. Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors. Cell Rep Med. 2021;2:100457 pubmed publisher

He H, Liao Q, Zhao C, Zhu C, Feng M, Liu Z, et al. Conditioned CAR-T cells by hypoxia-inducible transcription amplification (HiTA) system significantly enhances systemic safety and retains antitumor efficacy. J Immunother Cancer. 2021;9: pubmed publisher

Tong P, Gautam A, Windsor I, Travers M, Chen Y, Garcia N, et al. Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike. Cell. 2021;184:4969-4980.e15 pubmed publisher

de Mingo Pulido Á, Hänggi K, Celias D, Gardner A, Li J, Batista Bittencourt B, et al. The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake. Immunity. 2021;54:1154-1167.e7 pubmed publisher

Okamoto Y, Shikano S. Tyrosine sulfation and O-glycosylation of chemoattractant receptor GPR15 differentially regulate interaction with GPR15L. J Cell Sci. 2021;134: pubmed publisher

Li Q, Nie J, Wu J, Zhang L, Ding R, Wang H, et al. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell. 2021;184:2362-2371.e9 pubmed publisher

Palma Barqueros V, Crescente M, de la Morena M, Chan M, Almarza E, Revilla N, et al. A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis. Am J Hematol. 2021;96:E83-E88 pubmed publisher

Liao Q, Mao Y, He H, Ding X, Zhang X, Xu J. PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo. Biomark Res. 2020;8:57 pubmed publisher

Navare A, Mast F, Olivier J, Bertomeu T, Neal M, Carpp L, et al. Viral protein engagement of GBF1 induces host cell vulnerability through synthetic lethality. bioRxiv. 2020;221: pubmed publisher

Chen Y, Zuiani A, Fischinger S, Mullur J, Atyeo C, Travers M, et al. Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production. Cell. 2020;183:1496-1507.e16 pubmed publisher

Gao X, Cheng Y, Enten G, DeSantis A, Gaponenko V, Majetschak M. Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (CXC motif) receptor 4. J Biol Chem. 2020;295:14893-14905 pubmed publisher

Nagareddy B, Khan A, Kim H. Acetylation modulates the Fanconi anemia pathway by protecting FAAP20 from ubiquitin-mediated proteasomal degradation. J Biol Chem. 2020;: pubmed publisher

Willcox C, Vantourout P, Salim M, Zlatareva I, Melandri D, Zanardo L, et al. Butyrophilin-like 3 Directly Binds a Human Vγ4+ T Cell Receptor Using a Modality Distinct from Clonally-Restricted Antigen. Immunity. 2019;51:813-825.e4 pubmed publisher

Golec E, Rosberg R, Zhang E, Renstrom E, Blom A, King B. A cryptic non-GPI-anchored cytosolic isoform of CD59 controls insulin exocytosis in pancreatic β-cells by interaction with SNARE proteins. FASEB J. 2019;:fj201901007R pubmed publisher

Lotta L, Mokrosinski J, Mendes de Oliveira E, Li C, Sharp S, Luan J, et al. Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity. Cell. 2019;177:597-607.e9 pubmed publisher

Shlamkovich T, Aharon L, Koslawsky D, Einav Y, Papo N. Targeting the Tie2-αvβ3 integrin axis with bi-specific reagents for the inhibition of angiogenesis. BMC Biol. 2018;16:92 pubmed publisher

Herndler Brandstetter D, Ishigame H, Shinnakasu R, Plajer V, Stecher C, Zhao J, et al. KLRG1+ Effector CD8+ T Cells Lose KLRG1, Differentiate into All Memory T Cell Lineages, and Convey Enhanced Protective Immunity. Immunity. 2018;48:716-729.e8 pubmed publisher

Csizmar C, Petersburg J, Hendricks A, Stern L, Hackel B, Wagner C. Engineering Reversible Cell-Cell Interactions with Lipid Anchored Prosthetic Receptors. Bioconjug Chem. 2018;29:1291-1301 pubmed publisher

Gao X, Albee L, Volkman B, Gaponenko V, Majetschak M. Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by α1-adrenergic receptors at the heteromeric receptor complex. Sci Rep. 2018;8:2730 pubmed publisher

Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher